Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05699538 · ClinicalTrials.gov registry record · NA

Fatigability in Long COVID-19

A NA study of Long COVID, sponsored by VA Office of Research and Development.

Active
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT05699538 is a NA study of Long COVID that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 21 participants, below the 2,188-participant average among 50 other Long COVID trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05699538, a NA study of Long COVID, is active but no longer recruiting, sponsored by VA Office of Research and Development.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

The overall goal of this project is to advance the understanding of underlying mechanisms impacting performance fatigability and perceived fatigability in Veterans with post-COVID-19 fatigue and explore the safety and feasibility of a home-based "minimal-dose" resistance exercise program in this population. The central hypothesis is that declines in force capacity, skeletal muscle oxygen extraction, and affective responses to physical activity offer potential mechanisms through which fatigability is increased in Veterans with post-COVID-19 fatigue. Moreover, home-based resistance exercise delivered remotely may provide a safe and feasibility treatment option for targeting neuromuscular and neurobehavioral factors influencing fatigability severity in this population.

Conditions Studied

Long COVID

Interventions

  • BEHAVIORAL Minimal-Dose Home-Based Resistance Exercise

Study Locations (1)

District of Columbia

  • Washington DC VA Medical Center, Washington, DC - Washington D.C.

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2023-07-31
Est. Completion 2026-03-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05699538

The ClinicalTrials.gov registry entry for NCT05699538 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,188-participant average among 50 other Long COVID trials with a reported enrollment target (99% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Long COVID appearing as the primary indexed condition, and to 1 intervention - of which Minimal-Dose Home-Based Resistance Exercise is the first listed.

NCT05699538 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT05699538 about?

NCT05699538 is a clinical study titled "Fatigability in Long COVID-19". The overall goal of this project is to advance the understanding of underlying mechanisms impacting performance fatigability and perceived fatigability in Veterans with post-COVID-19 fatigue and explore the safety and feasibility of a home-based "minimal-dose" resistance exercise program in this pop...

What is the current status of trial NCT05699538?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 21 participants. The study started on 2023-07-31. Estimated completion is 2026-03-31.

What conditions does trial NCT05699538 study?

This clinical trial studies the following conditions: Long COVID.

What interventions are being tested in trial NCT05699538?

The interventions under investigation include: Minimal-Dose Home-Based Resistance Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT05699538?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05699538 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Long COVID

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Long COVID

All registered trials for this condition

District of Columbia

All trials with a study site in District of Columbia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.